GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Stella Pharma Corp (TSE:4888) » Definitions » Other Operating Expense

Stella Pharma (TSE:4888) Other Operating Expense : 円977.6 Mil (TTM As of Sep. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Stella Pharma Other Operating Expense?

Stella Pharma's Other Operating Expense for the three months ended in Sep. 2024 was 円0.0 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Sep. 2024 was 円977.6 Mil.

Stella Pharma's quarterly Other Operating Expense increased from Dec. 2023 (円205.3 Mil) to Mar. 2024 (円347.9 Mil) but then declined from Mar. 2024 (円347.9 Mil) to Sep. 2024 (円0.0 Mil).

Stella Pharma's annual Other Operating Expense increased from Mar. 2022 (円826.8 Mil) to Mar. 2023 (円1,013.7 Mil) but then declined from Mar. 2023 (円1,013.7 Mil) to Mar. 2024 (円977.6 Mil).


Stella Pharma Other Operating Expense Historical Data

The historical data trend for Stella Pharma's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stella Pharma Other Operating Expense Chart

Stella Pharma Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Other Operating Expense
Get a 7-Day Free Trial 951.41 862.34 826.76 1,013.72 977.60

Stella Pharma Quarterly Data
Mar19 Mar20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Sep24
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 217.37 206.94 205.35 347.95 -

Stella Pharma Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円977.6 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Stella Pharma Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Stella Pharma's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Stella Pharma Business Description

Traded in Other Exchanges
N/A
Address
3-2-7 Korai-bashi, Chuo-ku, Osaka Prefecture, Osaka, JPN, 541-0043
Stella Pharma Corp is a therapeutic drug research and development company. It is focused on the development of boron compounds, particularly used in boron neutron capture therapy (BNCT). The BNCT is a form of cancer radiation therapy for destroying cancer cells.

Stella Pharma Headlines

No Headlines